🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. Dexlansoprazole

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. Dexlansoprazole

    Takeda

    Pediatric Gastroesophageal Reflux Disease

    phase 1 small molecule terminated

    1 trial

  3. Dexlansoprazole

    Takeda

    Homeostasis

    phase 1 small molecule completed

    1 trial

  4. Dexlansoprazole Delayed Release Orally Disintegrating Tablets

    Takeda

    Bioavailability

    phase 1 small molecule completed

    1 trial

  5. Dexlansoprazole MR

    Takeda

    Gastroesophageal Reflux

    phase 1 small molecule completed

    1 trial

  6. Digoxin

    Takeda

    Cytomegalovirus (CMV)

    phase 1 small molecule completed

    1 trial

  7. Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor

    Takeda

    Alpha 1-Antitrypsin Deficiency

    phase 1 mab completed

    1 trial

  8. Esomeprazole Capsule

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  9. Fazirsiran

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  10. Febuxostat XR

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. Febuxostat XR

    Takeda

    Gout

    phase 1 small molecule completed

    1 trial

  12. Febuxostat XR 80 mg Capsule F1

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  13. Fucoidan (extract of Laminaria japonica)

    Takeda

    Healthy Volunteers

    phase 1 other completed

    1 trial

  14. HYQVIA

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. Human butyrylcholinesterase (HuBChE) derived from human plasma

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  16. INFS (Intranasal Fentanyl Spray)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  17. INV21 Low Dose

    Takeda

    Hand, Foot and Mouth Disease

    phase 1 mab completed

    1 trial

  18. ITI-214 Dose A

    Takeda

    Schizophrenia

    phase 1 small molecule terminated

    1 trial

  19. IXAZOMIB

    Takeda

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  20. IXAZOMIB

    Takeda

    Advanced Non-hematologic Malignancies

    phase 1 small molecule completed

    1 trial

  21. Icatibant (30 mg)

    Takeda

    Hereditary Angioedema (HAE)

    phase 1 small molecule completed

    1 trial

  22. Ixazomib

    Takeda

    Relapsed and Refractory Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  23. Ixazomib

    Takeda

    Glioblastoma

    phase 1 small molecule completed

    1 trial

  24. Ixazomib

    Takeda

    Light-Chain Amyloidosis

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources